Laboratoires SMB S.A.

Privately held: no public share price · Belgium

Assets

(1 total)
1Total Assets
0Approved
1Phase 3 / Filed
0Phase 1–2 / Early
2Diseases
Quick filter:
Showing 1 of 1 assets
Target & Modality
PravafenixNo recent activity
Phase 3
HMG-CoA reductase / PPAR-alphaSmall molecule
Atherosclerotic Cardiovascular DiseaseCardiovascular Disease / Dyslipidemia
Hypertriglyceridemia

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

No financial reports recorded.